Successful Treatment of Stereotactic Body Radiation Therapy Combined with Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Biliary Obstruction.
10.3904/kjim.2011.26.1.94
- Author:
Chan Kwon PARK
1
;
Si Hyun BAE
;
Hong Jun YANG
;
Ho Jong CHUN
;
Il Bong CHOI
;
Jong Young CHOI
;
Seung Kew YOON
Author Information
1. Department of Internal Medicine, The Catholic University of Korea School of Medicine, Seoul, Korea. baesh@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Hepatocellular carcinoma;
Stereotactic body radiation therapy;
Transarterial chemolipiodolization;
Obstructive jaundice
- MeSH:
Carcinoma, Hepatocellular/complications/*therapy;
*Chemoembolization, Therapeutic;
Combined Modality Therapy;
Humans;
Jaundice, Obstructive/etiology/therapy;
Liver Neoplasms/complications/*therapy;
Male;
Middle Aged;
*Radiosurgery
- From:The Korean Journal of Internal Medicine
2011;26(1):94-98
- CountryRepublic of Korea
- Language:English
-
Abstract:
Conventional radiation therapy (RT) is a widely recognized treatment for hepatocellular carcinoma (HCC). However, conventional RT plays only a limited role in HCC treatment because of its low efficacy and the low tolerance of the liver for this modality. Stereotactic body radiation therapy (SBRT) was recently developed and represents the most advanced radiation therapy technique currently available. It can deliver a high dose in a short time to well-defined hepatic tumors, with rapid dose fall-off gradients. We believe that SBRT with transarterial chemolipiodolization (TACL) may prove promising as a combined treatment modality for HCC due to its precision and relative safety. Here we present a case of successful treatment of advanced HCC with obstructive jaundice using this combined modality.
